Related Experiment Videos
The radioimmunoguided surgery (RIGS) system as a diagnostic tool
1Division of Surgical Oncology, The Arthur G. James Cancer Hospital and Research Institute, The Ohio State University, Columbus, Ohio, USA.
Surgical Oncology Clinics of North America
|November 21, 1998
Summary
Radioimmunoguided surgery (RIGS) enhances cancer detection during operations. This technique uses a gamma probe to find radiolabeled tissues, improving surgical staging for various cancers like colorectal and breast cancer.
Area of Science:
- Oncology
- Surgical Innovation
- Medical Imaging
Background:
- Intraoperative detection of malignancy remains a challenge in surgery.
- Accurate staging is crucial for effective cancer treatment planning.
- Existing methods may not always provide sufficient detail for complex cases.
Purpose of the Study:
- To introduce and evaluate the Radioimmunoguided Surgery (RIGS) system.
- To assess the efficacy of RIGS in improving intraoperative detection of cancer.
- To explore the application of RIGS across various cancer types.
Main Methods:
- The RIGS system employs a hand-held gamma radiation detection probe.
- Radioactive tumor-associated targeting agents (antibodies or peptides) are preadministered.
- The probe identifies radioactive tissues, aiding surgeons in detecting malignant areas.
Main Results:
- Favorable clinical experience reported in colorectal cancer, leading to better intraoperative staging.
- Encouraging early results observed in clinical trials for pancreatic, breast, ovarian, and prostate cancers.
- RIGS provides surgeons with enhanced information on disease patterns and individual patient status.
Conclusions:
- Radioimmunoguided surgery (RIGS) shows significant promise for improving intraoperative cancer detection and staging.
- The system has demonstrated positive outcomes in multiple cancer types, including colorectal, pancreatic, breast, ovarian, and prostate cancers.
- Future advancements in targeting agents are expected to further enhance RIGS system performance.